The Respiratory Burst of Eosinophils

  • Giuliano Zabucchi
  • Renzo Menegazzi
  • Pierluigi Patriarca


The first report on the ability of the eosinophils to perform the respiratory burst appeared in 1968.1 At that time, the respiratory burst of neutrophils was already known in several details, and reviews on the subject were available.2–5 This tells clearly enough what the rank of the eosinophil is, relative to the neutrophil, in the theme of respiratory burst—a situation similar to that of the second born son in a family whose performances are inevitably evaluated looking at the oldest son. In other words, the question underlying the research on the eosinophil respiratory burst has often, if not always, been whether the eosinophil could do what the neutrophil was already known to be able to do. It is therefore inevitable, in such a presentation, to refer frequently to neutrophils and to slip often into comparisons between eosinophils and neutrophils.


Respiratory Burst Chronic Granulomatous Disease Schistosoma Mansoni Human Eosinophil Eosinophil Peroxidase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cline MJ, Hanifin J, Lehrer RI: Phagocytosis by human eosinophils. Blood 32: 922–934, 1968.PubMedGoogle Scholar
  2. 2.
    Karnovsky ML: Metabolic basis of phagocytic activity. Physiol Rev 42: 143–168, 1962.PubMedGoogle Scholar
  3. 3.
    Cline MJ: Metabolism of the circulating leukocyte. Physiol Rev 45: 674–720, 1965.PubMedGoogle Scholar
  4. 4.
    Karnovsky ML: The metabolism of leukocytes. Ser Haematol 5: 156–165, 1968.Google Scholar
  5. 5.
    Beck WS: Leukocyte metabolism. Semin Hematol 1: 69–93, 1968.Google Scholar
  6. 6.
    Bass DA, Grover WH, Lewis JC, et al: Comparison of human eosinophils from normals and patients with eosinophilia. J Clin Invest 66: 1265–1273, 1980.PubMedCrossRefGoogle Scholar
  7. 7.
    Mickenberg D, Root RK, Wolff SM: Bactericidal and metabolic properties of human eosinophils. Blood 39: 67–80, 1972.PubMedGoogle Scholar
  8. 8.
    Baehner RL, Johnston RB Jr: Metabolic and bactericidal activity of human eosinophils. Br J Haematol 20: 277–285, 1971.PubMedCrossRefGoogle Scholar
  9. 9.
    Tauber AI, Goetzl EJ, Babior BM: The production of superoxide by human eosinophils. Blood 48: 968, 1976.Google Scholar
  10. 10.
    DeChatelet LR, Shirley PS, McPhail LC, et al: Oxidative metabolism of the human eosinophil. Blood 50: 525–535, 1977.PubMedGoogle Scholar
  11. 11.
    Tauber AI, Goetzl EJ, Babior BM: Unique characteristics of superoxide production by human eosinophils in eosinophilic states. Inflammation 3: 261–272, 1979.PubMedCrossRefGoogle Scholar
  12. 12.
    Bujak JS, Root RK: The role of peroxidase in the bactericidal activity of human blood eosinophils. Blood 43: 727–736, 1974.PubMedGoogle Scholar
  13. 13.
    Yazdanbakhsh M, Eckmann CM, Roos D: Characterization of the interaction of human eosinophils and neutrophils with opsonized particles. J Immunol 135: 1378–1384, 1985.PubMedGoogle Scholar
  14. 14.
    Rossi F: The O2- forming NADPH-oxidase of the phagocytes. Nature, mechanisms of activation and functions. Biochim Biophys Acta Rev Bioenerg 853: 65–89, 1986.Google Scholar
  15. 15.
    Beswick PH, Kay AB: The effect of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils. Clin Exp Immunol 43: 399–407, 1981.PubMedGoogle Scholar
  16. 16.
    Learn DB, Brestel EP: A comparison of superoxide production by human eosinophils and neutrophils. Agents Actions 12: 485–488, 1982.PubMedCrossRefGoogle Scholar
  17. 17.
    Yazdanbakhsh M, Eckermann CM, Bot A AM, et al: Bactericidal action of eosinophils from normal human blood. Infect Immun 53: 192–198, 1986.PubMedGoogle Scholar
  18. 18.
    Pincus SH, Schooley WR, DiNapoli AM, Et Al: Metabolic heterogeneity of eosinophils from normal and hypereosinophilic patients. Blood 58: 1175–1181, 1981.PubMedGoogle Scholar
  19. 19.
    Winqvist I, Olofsson T, Olsson I, et al: Altered density, metabolism and surface receptors of eosinophils in eosinophilia. Immunology 47: 531–538, 1982.PubMedGoogle Scholar
  20. 20.
    Prin L, Charon J, Capron M, et al: Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density. Clin Exp Immunol 57: 735–742, 1984.PubMedGoogle Scholar
  21. 21.
    Capron M, Spiegelberg HL, Prin L, et al: Role of IgE receptors in effector function of human eosinophils. J Immunol 132: 462–468, 1984.PubMedGoogle Scholar
  22. 22.
    Portmann P, Koppel P, Jörg A: An improved method for the isolation of eosinophilic leukocytes from normal human blood. Experientia 36: 139–141, 1980.PubMedCrossRefGoogle Scholar
  23. 23.
    Shutt PA, Graziano FM, Wallow IH, et al: Comparison of superoxide generation and luminol dependent chemiluminescence with eosinophils and neutrophils from normal individuals. J Lab Clin Med 106: 638–645, 1985.Google Scholar
  24. 24.
    Shutt PA, Graziano FM, Busse WW: Enhanced eosinophil luminol-dependent chemiluminescence in allergic rhinitis. J Allergy Clin Immunol 77: 702–708, 1986.CrossRefGoogle Scholar
  25. 25.
    Pincus SH, Butterworth AE, David JR, et al: Antibody-dependent eosinophil-mediated damage to schistosomula of Schistosoma mansoni: Lack of requirement for oxidative metabolism. J Immunol 126: 1794–1799, 1981.PubMedGoogle Scholar
  26. 26.
    Thorne JIK, Richardson BA, Veith MC, et al: Partial purification and biological properties of an eosinophil-activating factor. Eur J Immunol 15: 1083–1091, 1985.PubMedCrossRefGoogle Scholar
  27. 27.
    Pincus SH, DiNapoli AM, Schooley WK: Superoxide production by eosinophils: Activation by histamine. J Invest Dermatol 79: 53–57, 1982.PubMedCrossRefGoogle Scholar
  28. 28.
    Seligman BE, Fletcher MP, Gallin JI: Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes. J Immunol 130: 1902–1909, 1983.Google Scholar
  29. 29.
    Yamashita T, Someya A, Hara E: Response of superoxide anion production by guinea-pig eosinophils to various soluble stimuli: Comparison to neutrophils. Arch Biochem Biophys 241: 447–452, 1985.PubMedCrossRefGoogle Scholar
  30. 30.
    Petty HR, Francis JW: Polymorphonuclear leukocyte histamine receptors: Occurrence in cell surface clusters and their redistribution during locomotion. Proc Natl Acad Sei USA 83: 4332–4335, 1986.CrossRefGoogle Scholar
  31. 31.
    Palmblad J, Gyllenhammar H, Lindgren JA, et al: Effects of leukotrienes and f–Met-Leu-Phe on oxidative metabolism of neutrophils and eosinophils. J Immunol 132: 3041–3045, 1984.PubMedGoogle Scholar
  32. 32.
    Roberts RL, Gallin JI: Rapid method for isolation of normal human peripheral blood eosinophils on discontinuous Percoll gradients and comparison with neutrophils. Blood 65: 433–440, 1985.PubMedGoogle Scholar
  33. 33.
    Tsujimoto M, Yokota S, Vilcek J, et al: Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biophys Res Commun 137: 1094–1100, 1986.PubMedCrossRefGoogle Scholar
  34. 34.
    Klebanoff SJ, Vadas MA, Harlan JM, et al: Stimulation of neutrophils by tumor necrosis factor. J Immunol 136: 4220–4225, 1986.PubMedGoogle Scholar
  35. 35.
    Lopez AF, Williamson DJ, Gamble JR, et al: Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression and survival. J Clin Invest 78: 1220–1228, 1986.PubMedCrossRefGoogle Scholar
  36. 36.
    Silberstein DS, David JR: Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proc Natl Acad Sei USA 83: 1055–1059, 1986.CrossRefGoogle Scholar
  37. 37.
    Pincus SH, Dessein A, Lenzi H, et al: Eosinophil-mediated killing of schistosomula of Schistosoma mansoni: Oxidative requirement for enhancement by eosinophil colony stimulating factor (CSF-a) and supernatants with eosinophil cytotoxicity enhancing activity (E-CEA). Cell Immunol 87: 424–433, 1984.PubMedCrossRefGoogle Scholar
  38. 38.
    Winqvist I, Oloffson T, Olsson I: Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein. Immunology 51: 1–8, 1984.PubMedGoogle Scholar
  39. 39.
    Pincus SH: Eosinophil–particle interactions: A model system for study of cellular adherence and activation. Cell Immunol 86: 460–471, 1984.PubMedCrossRefGoogle Scholar
  40. 40.
    Henderson WR, Jörg A, Klebanoff SJ: Eosinophil peroxidase-mediated inactivation of leukotrienes B4, C4 and D4. J Immunol 128: 2609–2613, 1982.PubMedGoogle Scholar
  41. 41.
    Rand TH, Colley DG: Influence of a lymphokine fraction containing eosinophil stimulation promot-er (ESP) on oxidative and degranulation responses of murine eosinophils. Cell Immunol 71: 334–345, 1982.PubMedCrossRefGoogle Scholar
  42. 42.
    Vadas MA, Varigos G, Nicola N, et al: Eosinophil activation by colony-stimulating factor in man: Metabolic effects and analysis by flow cytometry. Blood 61: 1232–1241, 1983.PubMedGoogle Scholar
  43. 43.
    Kulczycki A Jr: Human neutrophils and eosinophils have structurally distinct Fc receptors. J Immu-nol 133: 849–853, 1984.Google Scholar
  44. 44.
    Capron M, Capron A, Dessaint JP, et al: Fc receptors for IgE on human and rat eosinophils. J. Immunol 126: 2087–2092, 1981.PubMedGoogle Scholar
  45. 45.
    Anwar ARE, Kay AB: Membrane receptors for IgG and complement (C4, C3b and C3d) on human eosinophils and neutrophils and their relation to eosinophilia. J Immunol 119: 976–982, 1977.PubMedGoogle Scholar
  46. 46.
    Weller PF, Goetzl EJ: The regulatory and effector roles of eosinophils. Adv Immunol 27: 339–371, 1979.PubMedCrossRefGoogle Scholar
  47. 47.
    Klebanoff SJ, Clark RA: The metabolic burst, in Klebanoff SJ, Clark RA (eds): The Neutrophil: Function and Clinical Disorders. Amsterdam, North-Holland, 1978, p 283.Google Scholar
  48. 48.
    Klebanoff SJ, Durack DT, Rosen H, et al: Functional studies on human peritoneal eosinophils. Infect Immun 17: 167–173, 1977.PubMedGoogle Scholar
  49. 49.
    Tchernitchin A, Tchernitchin X: Characterization of the estrogen receptors in the uterine and blood eosinophil leukocytes. Experientia 32: 1240–1242, 1976.PubMedCrossRefGoogle Scholar
  50. 50.
    Tchernitchin A, Tchernitchin X: The binding of estradiol to human polynuclear eosinophilic leuko-cytes. CR Acad Sei (Paris) 280: 1477–1480, 1975.Google Scholar
  51. 51.
    Peterson AP, Altman LC, Hill JS, et al: Glucocorticoid receptors in normal human eosinophils: comparison with neutrophils. J Allergy Clin Immunol 68: 212–217, 1981.PubMedCrossRefGoogle Scholar
  52. 52.
    Saito H, Yamada K, Breard J, et al: A monoclonal antibody reactive with human eosinophils. Blood 67: 50–56, 1986.PubMedGoogle Scholar
  53. 53.
    Babior BM: The nature of the NADPH-oxidase, in Gallin JI, Fauci AS (eds): Advances in Host Defense Mechanisms. New York, Raven, 1983, vol 3: Chronic Granulomatous Disease, p 91.Google Scholar
  54. 54.
    Mills EL, Quie PG: Inheritance of chronic granulomatous disease, in Gallin JI, Fauci AS (eds): Advances in Host Defense Mechanisms, Chronic Granulomatous Disease, vol 3. New York, Raven, 1983, p 25.Google Scholar
  55. 55.
    Nathan DG, Baehner RL, Weaver DK: Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease. J Clin Invest 48: 1895–1901, 1969.PubMedCrossRefGoogle Scholar
  56. 56.
    DeChatelet LR, Migler RA, Shirley PS, et al: Enzymes of oxidative metabolism in the human eosinophil. Proc Soc Exp Biol Med 158: 537–541, 1978.PubMedGoogle Scholar
  57. 57.
    Segal AW, Garcia R, Goldstone AH, et al: Cytochrome 6–245 of neutrophils is also present in human monocytes, macrophages and eosinophils. Biochem J 196: 363–367, 1981.PubMedGoogle Scholar
  58. 58.
    Segal AW: Chronic granulomatous disease: A model for studying the role of cytochrome 6–245 in health and disease, in Gallin JI, Fauci AS (eds): Advances in Host Defense Mechanisms. New York, Raven, 1983, vol 3: Chronic Granulomatous Disease, p 121.Google Scholar
  59. 59.
    West BC, Gelb NA, Rosenthal AS: Isolation and partial characterization of human eosinophil granules. Am J Pathol 81: 575–588, 1975.PubMedGoogle Scholar
  60. 60.
    Dri P, Cramer R, Soranzo MR, et al: New approaches to the detection of myeloperoxidase deficiency. Blood 60: 323–327, 1982.PubMedGoogle Scholar
  61. 61.
    DeChatelet LR, Migler RA, Shirley PS, et al: Comparison of intracellular bactericidal activities of human neutrophils and eosinophils. Blood 52: 609–617, 1978.PubMedGoogle Scholar
  62. 62.
    Cline MJ: Microbicidal activity of human eosinophils. J Reticuloendothel Soc 12: 332–339, 1972.PubMedGoogle Scholar
  63. 63.
    Gilman PA, Jackson DP, Guild HG: Congenital agranulocytosis: Prolonged survival and terminal acute leukemia. Blood 36: 576–585, 1970.PubMedGoogle Scholar
  64. 64.
    Migler R, Dechatelet LR, Bass DA: Human eosinophilic peroxidase: Role in bactericidal activity. Blood 51: 445–456, 1978.PubMedGoogle Scholar
  65. 65.
    Jong EC, Henderson WR, Klebanoff SJ: Bactericidal activity of eosinophil peroxidase. J Immunol 124: 1378–1382, 1980.PubMedGoogle Scholar
  66. 66.
    Klebanoff SJ, Clark RA: Anti-microbial systems, in Klebanoff SJ, Clark RA (eds): The Neutrophil: Function and Clinical Disorders. Amsterdam, North-Holland, 1978, p 409.Google Scholar
  67. 67.
    Presentey B, Szapiro L: Hereditary deficiency of peroxidase and phospholipids in eosinophilic granulocytes. Acta Haematol 41: 359–362, 1969.PubMedCrossRefGoogle Scholar
  68. 68.
    Presentey B, Joshua H: Peroxidase and phospholipid deficiency in human eosinophilic granulocytes. A marker in populations genetics. Experientia 38: 628–629, 1982.PubMedCrossRefGoogle Scholar
  69. 69.
    Hamers MN, Bot A AM, Weening RS, et al: Kinetics and mechanism of bactericidal action of human neutrophils against Escherichia coli. Blood 64: 635–641, 1984.PubMedGoogle Scholar
  70. 70.
    Lehrer RI: Measurement of candidacidal activity of specific leukocyte types in mixed cell popula-tion. II. Normal and chronic granulomatous disease eosinophils. Infect Immun 3: 800–802, 1971.PubMedGoogle Scholar
  71. 71.
    Dessein AJ, David JR: The eosinophil in parasitic disease, in Gallin JI, Fauci AS (eds): Advances in Host Defense Mechanisms. New York, Raven, 1982, vol 1: Phagocytic Cells, p 243.Google Scholar
  72. 72.
    Butterworth AE, Sturrock RF, Houba V, et al: Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature (Lond) 256: 727–729, 1975.CrossRefGoogle Scholar
  73. 73.
    Mahmoud AAF, Warren KS, Peters PA: A role for the eosinophil in acquired resistence to Schistosoma mansoni infection as determined by antieosinophil serum. J Exp Med 142: 805–813, 1975.PubMedCrossRefGoogle Scholar
  74. 74.
    Olds GR, Mahmoud AAF: Role of host granulomatous response in murine schistosomiasis mansoni. Eosinophil mediated destruction of eggs. J Clin Invest 66: 1191–1199, 1980.PubMedCrossRefGoogle Scholar
  75. 75.
    Butterworth AE, David JR, Mahmoud AAF, et al: Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: Damage by purified eosinophils. J Exp Med 145: 136–150, 1977.PubMedCrossRefGoogle Scholar
  76. 76.
    Pincus SH, Butterworth AE, David JR, et al: Antibody-dependent eosinophil-mediated damage to schistosomula of Schistosoma mansoni: Lack of requirement for oxidative metabolism. J Immunol 126: 1794–1799, 1981.PubMedGoogle Scholar
  77. 77.
    Anwar AR, Smithers SR, Kay AB: Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: Requirement for complement in prefer-ential killing by eosinophils. J Immunol 122: 628–637, 1979.PubMedGoogle Scholar
  78. 78.
    Vadas MA, David JR, Butterworth A, et al: A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. J Immunol 122: 1228–1236, 1979.PubMedGoogle Scholar
  79. 79.
    Kazura JW, Fanning MM, Blumer JL, et al: Role of cell-generated hydrogen peroxide in gran- ulocyte-mediated killing of schistosomula of Schistosoma mansoni in vitro. J Clin Invest 67: 93–102, 1981.PubMedCrossRefGoogle Scholar
  80. 80.
    Bass DA, Szejda P: Eosinophils versus neutrophils in host defense. Killing of newborn larvae of Trichinella spiralis by human granulocytes in vitro. J Clin Invest 64: 1415–1422, 1979.PubMedCrossRefGoogle Scholar
  81. 81.
    Kazura JW, Aikawa M: Host defense mechanisms against Trichinella spiralis infection in the mouse: Eosinophil-mediated destruction of newborn larvae in vitro. J Immunol 124: 355–361, 1980.PubMedGoogle Scholar
  82. 82.
    Gleich GJ, Loegering DA: Immunobiology of eosinophils. Annu Rev Immunol 2: 429–459, 1984.PubMedCrossRefGoogle Scholar
  83. 83.
    Bass DA, Szejda P: Mechanisms of killing of newborn larvae of Trichinella spiralis by neutrophils and eosinophils. J Clin Invest 64: 1558–1564, 1979.PubMedCrossRefGoogle Scholar
  84. 84.
    Kazura JW, deBrito P, Rabbege J, et al: Role of granulocyte oxygen products in damage of Schistosoma mansoni eggs in vitro. J Clin Invest 75: 1297–1307, 1985.PubMedCrossRefGoogle Scholar
  85. 85.
    Jong EC, Mahmoud AAF, Klebanoff SJ: Peroxidase-mediated toxicity to schistosomula of Schistosoma mansoni. J Immunol 126: 468–471, 1981.PubMedGoogle Scholar
  86. 86.
    Buys J, Wever R, Ruitenberg EJ: Myeloperoxidase is more efficient than eosinophil peroxidase in the in vitro killing of newborn larvae of Trichinella spiralis. Immunology 51: 601–607, 1984.PubMedGoogle Scholar
  87. 87.
    David JR, Butterworth AE, Remold HG, et al: Antibody-dependent, eosinophil-mediated damage to 51 Cr labeled schistosomula of Schistosoma mansoni: Effect of metabolic inhibitors and other agents which alter cell function. J Immunol 118: 2221–2229, 1977.PubMedGoogle Scholar
  88. 88.
    Goetzl EJ: The conversion of leukotriene C4 to isomers of leukotriene B4 by human eosinophil peroxidase. Biochem Biophys Res Commun 106: 270–275, 1982.PubMedCrossRefGoogle Scholar
  89. 89.
    Ziltener HJ, Chavaillaz PA, Jörg A: Leukotriene formation by eosinophil leukocytes. Analysis with ion-pair high pressure liquid chromatography and effect of the respiratory burst. Hoppe-Seylers Z Physiol Chem 364: 1029–1037, 1983.PubMedCrossRefGoogle Scholar
  90. 90.
    Henderson WR, Chi EY, Klebanoff SJ: Eosinophil peroxidase-induced mast cell secretion. J Exp Med 152: 265–279, 1980.PubMedCrossRefGoogle Scholar
  91. 91.
    Clark RA: Extracellular effects of the myeloperoxidase-hydrogen peroxide-halide system, in Weissmann G (ed): Advances in Inflammation Research. New York, Raven, 1983, vol 5, p 107.Google Scholar
  92. 92.
    Jong EC, Klebanoff SJ: Eosinophil-mediated mammalian tumor cell cytotoxicity: Role of the peroxidase system. J Immunol 124: 1949–1953, 1980.PubMedGoogle Scholar
  93. 93.
    Nogueira NM, Klebanoff SJ, Cohn ZA: T. cruzi: Sensitization to macrophage killing by eosinophil peroxidase. J Immunol 128: 1705–1708, 1982.PubMedGoogle Scholar
  94. 94.
    Agosti JM, Ayars GH, Altman LC, et al: Eosinophil peroxidase-hydrogen peroxide-halide mediated pneumocyte injury. J Allergy Clin Immunol 77: 235, 458a, 1986.Google Scholar
  95. 95.
    Locksley RM, Wilson CB, Klebanoff SJ: Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes. J Clin Invest 69: 1099–1111, 1982.PubMedCrossRefGoogle Scholar
  96. 96.
    Zabucchi G, Menegazzi R, Soranzo MR, et al: Uptake of human eosinophil peroxidase by human neutrophils. Am J Pathol 124: 510–518, 1986.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Giuliano Zabucchi
    • 1
  • Renzo Menegazzi
    • 1
  • Pierluigi Patriarca
    • 1
  1. 1.Institute of General PathologyUniversity of TriesteTriesteItaly

Personalised recommendations